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background: Previous studies have shown that drug-eluting balloon (DEB) can be a useful treatment for patients with restenosis after 
stent implantation. However, the factors that optimize the results of DEB angioplasty have not been elucidated. This study was performed 
to investigate the factors related with repeat-instent restenosis (ISR) after DEB angioplasty.
methods: A total of 214 patients (266 lesions) who was treated with DEB angioplasty for ISR from September 2009 to August 2013, were 
enrolled in this study. Retrospective analysis was performed for factors predicting repeat-ISR in view of patients, lesions and procedure.
results: Of 214 patients, 135 (61%) received angiographic follow-up at 6-9 months. Binary restenosis was identified in 43 lesions (24%). 
The patient factor associated with repeat-ISR was low body mass index (24.7±2.8 kg/m2 vs. 23.0±2.6 kg/m2, P = 0.007). In terms of lesion 
characteristics, complex lesions which were defined as Total occlusion, Angulation, Bifurcation, Ostial lesion and Overlapped stents were 
associated with repeat-ISR. Because some lesions had more than 2 characteristics, we created TABOO score by adding 1 point each 
for characteristic, and repeat ISR rates tended to increase with TABOO score (10.4% in score 0, 25.7% in score 1, and 61.1% in score 
2, respectively, P < 0.001). On the other hands, in repeat-ISR lesions, mean DEB inflation time was shorter (52.2±17.1 sec vs. 59.3±16.6 
sec, P=0.024) and inflated DEB/Stent diameter was smaller than that of patent lesions (1.10±0.09 vs. 1.06±0.08, P =0.034). Multivariable 
logistic regression analysis showed that DEB inflation time <60 seconds (OR, 3.261; 95% CI, 1.25 - 8.51; P = 0.016), TABOO score2 (OR, 
5.201; 95% CI, 1.25-21.64; P = 0.023) were independent factors predicting repeat-ISR. Target lesion revascularization rate at 12-month 
was significant different between DEB inflation time ≥60 sec group and <60 sec group (13.7% vs. 5.6%, Log Rank P = 0.045).
Conclusion:  In DEB angioplasty for ISR, long DEB inflation time and high pressure inflation of DEB up to the diameter of 10% larger than 
that of implanted stents could improve the outcomes, especially in complex lesions.
